Covered recipient · General Payments record
TAZEEN REHMAN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$2,617.19
- Reported across 153 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.34 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $157.00 | 13 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.40 | 2 |
| Aurinia Pharma U.S., Inc. | $29.65 | 1 |
| Amgen Inc. | $23.01 | 1 |
| PFIZER INC. | $21.26 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.69 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933978 | CMS |
| ABBVIE INC. | $19.14 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933980 | CMS |
| ABBVIE INC. | $2.83 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933982 | CMS |
| ABBVIE INC. | $18.70 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933984 | CMS |
| ABBVIE INC. | $5.87 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933986 | CMS |
| ABBVIE INC. | $25.31 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933988 | CMS |
| ABBVIE INC. | $4.96 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933990 | CMS |
| ABBVIE INC. | $34.73 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933992 | CMS |
| ABBVIE INC. | $5.00 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933994 | CMS |
| ABBVIE INC. | $13.33 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933996 | CMS |
| ABBVIE INC. | $4.05 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105933998 | CMS |
| ABBVIE INC. | $4.73 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105934000 | CMS |
| ABBVIE INC. | $11.66 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105934002 | CMS |
| Amgen Inc. | $23.01 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116051950 | CMS |
| Aurinia Pharma U.S., Inc. | $29.65 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150690567 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.02 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101533505 | CMS |
| Novartis Pharmaceuticals Corporation | $21.57 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087315501 | CMS |
| Novartis Pharmaceuticals Corporation | $28.83 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087315527 | CMS |
| PFIZER INC. | $21.26 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131428747 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.